Grand Pharmaceutical Group Limited (HKG:0512)
Hong Kong · Delayed Price · Currency is HKD 8.18
-0.02 (-0.24%)
At close: Dec 12, 2025
HKG:0512 Market Cap
HKG:0512 has a market cap or net worth of 28.64 billion as of December 12, 2025. Its market cap has increased by 83.82% in one year.
Market Cap
28.64B
Enterprise Value
31.06B
Revenue
11.70B
Ranking
n/a
PE Ratio
13.76
Stock Price
8.18
Market Cap Chart
Since February 28, 1996, HKG:0512's market cap has increased from 1.42B to 28.64B, an increase of 1,911.62%. That is a compound annual growth rate of 10.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 28.64B | 70.42% |
| Dec 31, 2024 | 16.81B | 16.78% |
| Dec 29, 2023 | 14.39B | -11.29% |
| Dec 30, 2022 | 16.22B | -29.24% |
| Dec 31, 2021 | 22.93B | -6.10% |
| Dec 31, 2020 | 24.42B | 70.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 274.43B |
| Hansoh Pharmaceutical Group Company | 257.41B |
| JD Health International | 188.25B |
| Innovent Biologics | 144.64B |
| WuXi Biologics | 138.62B |
| Sino Biopharmaceutical | 121.03B |
| Akeso | 107.59B |
| Sichuan Kelun-Biotech Biopharmaceutical | 96.12B |